Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Cited by (1,003)

Items 301–400 of 1,003

1. Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA
   Surasak Kasetsirikul, Muhammad Umer, Narshone Soda, Kamalalayam Rajan Sreejith, Muhammad J. A. Shiddiky, Nam‐Trung Nguyen · 2020 · The Analyst
2. Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
   Ed Slot, Boris M. Hogema, Chantal B. E. M. Reusken, Johan H J Reimerink, Michel Molier, Jan H. M. Karregat, Johan IJlst, Vĕra M J Novotny, René A. W. van Lier, Hans L. Zaaijer · 2020 · Nature Communications
3. Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
   Heli Harvala, Matthew L. Robb, Nick A. Watkins, Samreen Ijaz, Steve Dicks, Monika Patel, Piyada Supasa, Wanwisa Dejnirattisai, Chang Liu, Juthathip Mongkolsapaya et al. · 2020 · Transfusion Medicine
4. COVID‐19 diagnostic testing: Technology perspective
   Meng Xu, Dan Wang, Hongye Wang, Xiaomei Zhang, Te Liang, Jiayu Dai, Meng Li, Jiahui Zhang, Kai Zhang, Danke Xu et al. · 2020 · Clinical and Translational Medicine
5. Immune response following infection with SARS‐CoV ‐2 and other coronaviruses: A rapid review
   Éamon Ó Murchú, Paula Byrne, Kieran Anthony Walsh, Paul G. Carty, Máire A Connolly, Cillian F De Gascun, Karen Jordan, Mary Keoghan, Kirsty K O’Brien, Michelle O’Neill et al. · 2020 · Reviews in Medical Virology
6. Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
   Leila Mohamed Khosroshahi, Mohsen Rokni, Tahmineh Mokhtari, Farshid Noorbakhsh · 2021 · International Immunopharmacology
7. Multidisciplinary guidance for safe tracheostomy care during the COVID‐19 pandemic: the NHS National Patient Safety Improvement Programme (NatPatSIP)
   Brendan A. McGrath, Nichola Ashby, Martin Birchall, Paul Dean, C. Doherty, Kathleen Ferguson, J. Gimblett, Michael P. W. Grocott, Tony Jacob, Cyrus J. Kerawala et al. · 2020 · Anaesthesia
8. Antibody responses against SARS‐CoV‐2 in COVID‐19 patients
   Anding Liu, Ying Li, Jing Peng, Yuancheng Huang, Dong Xu · 2020 · Journal of Medical Virology
9. COVID-19: a review
   Constantinos Papadopoulos, Sebastian Jen Kin Chong, Shameen Jaunoo · 2020 · IJS Short Reports
10. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
    Liis Haljasmägi, Ahto Salumets, Anna Pauliina Rumm, Meeri Jürgenson, Ekaterina Krassohhina, Anu Remm, Hanna Sein, Lauri Kareinen, Olli P. Vapalahti, Tarja A. Sironen et al. · 2020 · Scientific Reports
11. Applying the electronic nose for pre-operative SARS-CoV-2 screening
    Anne G. W. E. Wintjens, Kim F.H. Hintzen, Sanne M.E. Engelen, Tim Lubbers, Paul H. M. Savelkoul, Geertjan Wesseling, Job A.M. van der Palen, Nicole D. Bouvy · 2020 · Surgical Endoscopy
12. Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients
    Elisa Kortela, Vesa Kirjavainen, Maarit J. Ahava, Suvi Tuulia Jokiranta, Anna But, Anna L. Lindahl, Anu Jääskeläinen, Annemarjut J. Jääskeläinen, Asko Järvinen, Pia Jokela et al. · 2021 · PLoS ONE
13. Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination
    Rafael Ramiro de Assis, Aarti Jain, Rie Nakajima, Algis Jasinskas, Saahir Khan, Anton M. Palma, Daniel M. Parker, Anthony H. Chau, Specimen Collection Group, Sina Hosseinian et al. · 2021 · npj Vaccines
14. SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
    Marzia Nuccetelli, Massimo Pieri, Sandro Grelli, Marco Ciotti, Roberto Miano, Massimo Andreoni, Sergio Bernardini · 2020 · Cell Death Discovery
15. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection
    Synat Keam, Dewi Megawati, Shailesh Kumar Patel, Ruchi Tiwari, Kuldeep Dhama, Harapan Harapan · 2020 · Reviews in Medical Virology
16. Post SARS-CoV-2 Guillain-Barré syndrome
    Souraya Arnaud, Clara Budowski, Sophie Ng Wing Tin, Bertrand Degos · 2020 · Clinical Neurophysiology
17. COVID-19 salivary signature: diagnostic and research opportunities
    Dipak Sapkota, Tine M. Søland, Hilde Kanli Galtung, Lars Peter Sand, Simone Giannecchini, Kelvin Kai‐Wang To, Maria Cássia Mendes-Corrêa, Daniel Giglio, Bengt Hasséus, Paulo Henrique Braz‐Silva · 2020 · Journal of Clinical Pathology
18. An Effective COVID-19 Vaccine Needs to Engage T Cells
    Karsten Sauer, Tim Harris · 2020 · Frontiers in Immunology
19. Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect
    Gabriel N. Maine, Kriselle Maris Lao, Subhashree Mallika Krishnan, Olabisi I. Afolayan-Oloye, Seyedalireza Fatemi, Sandeep Kumar, Lindsay VanHorn, Ashley Hurand, Elizabeth Sykes, Qian Sun · 2020 · Journal of Clinical Virology
20. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
    Vincent J. Venditto, Dalia Haydar, Ahmed Abdel‐Latif, John C. Gensel, Michael Anstead, Michelle G. Pitts, Jarrod W. Creameans, Timothy Joseph Kopper, Chi Peng, David J. Feola · 2021 · Frontiers in Immunology
21. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
    Bandar Alosaimi, Ayman Mubarak, Maaweya E. Hamed, Abdullah Z. Almutairi, Ahmed Ali Alrashed, Abdullah AlJuryyan, Mushira A. Enani, Faris Q Alenzi, Wael Alturaiki · 2021 · Frontiers in Immunology
22. SARS-CoV-2 antibody testing—questions to be asked
    Mustafa Kemal Özcürümez, Andreas Ambrosch, Oliver Frey, Verena Haselmann, Stefan Holdenrieder, Michael Kiehntopf, Michael Neumaier, Michael Walter, Folker Wenzel, Roman Wölfel et al. · 2020 · Journal of Allergy and Clinical Immunology
23. Pandemia COVID-19, la nueva emergencia sanitaria de preocupación internacional: una revisión
    R. Mojica Crespo, M. M. Morales-Crespo · 2020 · Medicina de Familia SEMERGEN
24. Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
    David Simón, Koray Taşçılar, Gerhard Krönke, Arnd Kleyer, Mario M. Zaiss, Franz Heppt, Christine Haie Meder, Raja Narayana Atreya, Entcho Klenske, Peter Dietrich et al. · 2020 · Nature Communications
25. SARS-CoV-2-specific ELISA development
    Vicky Roy, Stephanie Fischinger, Caroline G. Atyeo, Matthew D. Slein, Carolin Loos, Alejandro Benjamin Balazs, Corinne Luedemann, Michael Gerino Astudillo, Diane Yang, Duane R. Wesemann et al. · 2020 · Journal of Immunological Methods
26. What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
    Marc K. Hellerstein · 2020 · Vaccine X
27. Comparison of SARS-CoV-2 serological tests with different antigen targets
    Alix T. Coste, Katia Jaton, Matthaios Papadimitriou‐Olivgeris, Gilbert Greub, Antony Croxatto · 2020 · Journal of Clinical Virology
28. Assessment of Sequelae of COVID-19 Nearly 1 Year After Diagnosis
    Fangyuan Zhou, Meihui Tao, Luorui Shang, Yuhan Liu, Guangtao Pan, Yan Jin, Li Wang, Shaoke Hu, Jinxiao Li, Mengqi Zhang et al. · 2021 · Frontiers in Medicine
29. Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals
    Sang Il Kim, Jinsung Noh, Sujeong Kim, Younggeun Choi, Duck Kyun Yoo, Yonghee Lee, Hyunho Lee, Jongtak Jung, C. K. Kang, K. Song et al. · 2021 · Science Translational Medicine
30. Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection
    Xiao-Lin Jiang, Guo-Lin Wang, Xiang-Na Zhao, Fei-Hu Yan, Lin Yao, Z. Kou, Shengxiang Ji, Xiao-li Zhang, Cunbao Li, L. Duan et al. · 2021 · Nature Communications
31. Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies
    Kayoko Shioda, Max S. Y. Lau, Alicia N.M. Kraay, Kristin Nelson, Aaron Julius Siegler, Patrick Sean Sullivan, Matthew H. Collins, Joshua S. Weitz, Benjamin Alan Lopman · 2021 · Epidemiology
32. Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐19
    Costagliola, Giorgio, Spada, Erika, Consolini, Rita · 2021 · Immunity, Inflammation and Disease
33. Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera
    KY Oguntuyo, C. Stevens, Chuan-Tien Hung, Satoshi Ikegame, Joshua A. Acklin, S. Kowdle, Jillian C. Carmichael, Hsin-Ping Chiu, Kristopher D. Azarm, Griffin D Haas et al. · 2021 · mBio
34. SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies–a narrative review
    Rakesh Kumar, Cut Meurah Yeni, Niken Asri Utami, Rupali Masand, Rajesh Kumar Asrani, Shailesh Kumar Patel, Akshay Kumar, Mohd. Iqbal Yatoo, Ruchi Tiwari, Senthilkumar Natesan et al. · 2021 · Journal of Infection and Public Health
35. Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next
    Angeliki M. Angelidi, Matthew J. Belanger, Christos Socrates Mantzoros · 2020 · Metabolism
36. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?
    Julio Villena, Haruki Kitazawa · 2020 · Frontiers in Physiology
37. Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Survey Among 17 971 Healthcare and Administrative Personnel at Hospitals, Prehospital Services, and Specialist Practitioners in the Central Denmark Region
    Sanne Jespersen, Susan Mikkelsen, Thomas Greve, Kathrine Agergård Kaspersen, Martin Tolstrup, Jens Kjærgaard Boldsen, Jacob Dvinge Redder, Kent Jacob Nielsen, Anders Mønsted Abildgaard, Henrik Albert Kolstad et al. · 2020 · Clinical Infectious Diseases
38. Decay of Fc-dependent antibody functions after mild to moderate COVID-19
    W. Lee, K. Selva, Samantha K. Davis, B. Wines, A. Reynaldi, R. Esterbauer, Hannah G. Kelly, E. Haycroft, Hyon-Xhi Tan, J. Juno et al. · 2020 · medRxiv
39. Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
    Shiyu Sun, Yueqi Cai, Tian‐Zhang Song, Pu Yang, Lin Cheng, Hairong Xu, Jing Sun, Chaoyang Meng, Yifan Lin, Haibin Huang et al. · 2021 · Cell Research
40. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
    D. Pinato, J. Aguilar-Company, D. Ferrante, G. Hanbury, M. Bower, R. Salazar, O. Mirallas, A. Sureda, Andrea Plaja, M. Cucurull et al. · 2022 · The Lancet Oncology
41. Current laboratory diagnostics of coronavirus disease 2019 (COVID-19).
    Giuseppe Lippi, Camilla Mattiuzzi, Chiara Bovo, Mario Plebani · 2020 · Acta bio-medica dell'Ateneo parmense/Acta biomedica
42. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons
    Nele Wellinghausen, Dietmar Plonné, Meike Voss, Ralitsa Ivanova, Reinhard Frodl, Susanne Deininger · 2020 · Journal of Clinical Virology
43. Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review
    Antonio Russo, Carmine Minichini, Mario Starace, Roberta Astorri, Federica Calò, Nicola Coppola · 2020 · Infection and Drug Resistance
44. Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein
    Xiaohui Wang, Joy-Yan Lam, Wan‐Man Wong, Chun‐Kit Yuen, Jian‐Piao Cai, Shannon Wing‐Ngor Au, Jasper Fuk‐Woo Chan, Kelvin Kai‐Wang To, Kin‐Hang Kok, Kwok-Yung Yuen · 2020 · mBio
45. Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19
    Erik Hans Vogelzang, Floris C. Loeff, Ninotska I. L. Derksen, Simone Kruithof, Pleuni Ooijevaar‐de Heer, Gerard J. van Mierlo, Federica Linty, Juk Yee Mok, Wim J.E. van Esch, Sanne de Bruin et al. · 2020 · The Journal of Immunology
46. Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
    Khan Sharun, Ruchi Tiwari, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Senthilkumar Natesan, Jaideep Dhama, Yashpal Singh Malik, Harapan Harapan, Raj Kumar Singh, Kuldeep Dhama · 2020 · Expert Opinion on Biological Therapy
47. COVID-19 Convalescent Plasma: Now Is the Time for Better Science
    Sunny Dzik · 2020 · Transfusion Medicine Reviews
48. Guidelines: Anaesthesia in the context of COVID-19 pandemic
    Lionel J. Velly, Étienne Gayat, Hervé Quintard, Emmanuel Weiss, Audrey DE JONG, Philippe Cuvillon, Gérard Audibert, Julien Amour, Marc Beaussier, Matthieu Biais et al. · 2020 · Anaesthesia Critical Care & Pain Medicine
49. Diagnostic accuracy of serological tests and kinetics of severe acute respiratory syndrome coronavirus 2 antibody: A systematic review and meta‐analysis
    Daniel Shitu Mekonnen, Hylemariam Mihiretie Mengist, Awoke Derbie, Endalkachew Nibret, Abaineh Munshea, Hongliang He, Bofeng Li, Tengchuan Jin · 2020 · Reviews in Medical Virology
50. Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates
    Jim B. Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Danniel Zamora, Sarah A. McGuffin, Adrienne E. Shapiro, Victoria Louise Campbell, Christopher L. McClurkan, Lichen Jing, Robin Gross et al. · 2020 · Journal of Clinical Investigation
51. A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19
    Arthur Vengesai, Herald Midzi, Maritha Kasambala, Hamlet Mutandadzi, Tariro Lavender Mduluza-Jokonya, Simbarashe Rusakaniko, Francisca Mutapi, Thajasvarie Naicker, Takafira Mduluza · 2021 · Systematic Reviews
52. Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
    Huan Ma, Weihong Zeng, Xiang-Zhi Meng, Xiaoxue Huang, Yunru Yang, Dan Zhao, Peigen Zhou, Xiao-Fang Wang, Chang-Cheng Zhao, Yong-Jun Sun et al. · 2021 · Journal of Virology
53. Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers
    Tongyang Xiao, Yanrong Wang, Jing Yuan, Haocheng Ye, Lanlan Wei, Xuejiao Liao, Haiyan Wang, Shen Qian, Zhaoqin Wang, Lei Liu et al. · 2021 · Frontiers in Medicine
54. The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
    David Baker, Sandra Amor, Angray S. Kang, Klaus Schmierer, Gavin Giovannoni · 2020 · Multiple Sclerosis and Related Disorders
55. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays
    Baptiste Demey, N Daher, Catherine François, Jean‐Philippe Lanoix, Gilles Duverlie, Sandrine Castelain, Étienne Brochot · 2020 · Journal of Infection
56. Development and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 Infection
    Xuejiao Lina Hu, Qianyun Deng, Junmin Li, Jierong Chen, Zixia Wang, Xiqin Zhang, Zhixin Fang, Haijian Li, Yunhu Zhao, Yu Pan et al. · 2020 · mSphere
57. Physical Exercise as a Multimodal Tool for COVID-19: Could It Be Used as a Preventive Strategy?
    Diego Fernández‐Lázaro, Jerónimo J. González-Bernal, Nerea Sánchez-Serrano, Lourdes Jiménez Navascués, Ana Ascaso, Juan Mielgo‐Ayuso · 2020 · International Journal of Environmental Research and Public Health
58. The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines
    Jeremy Luban, Rachel A. Sattler, Elke Mühlberger, Jason D. Graci, Liangxian Cao, Marla L. Weetall, Christopher R. Trotta, Joseph M. Colacino, Sina Bavari, Caterina Strambio‐De‐Castillia et al. · 2020 · Virus Research
59. IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Henry M. Staines, Daniela E. Kirwan, David J Clark, Emily Rebecca Adams, Yolanda Sydney Augustin, Rachel Louise Byrne, Michael Cocozza, Ana I. Cubas-Atienzar, Luís E. Cuevas, Martina Cusinato et al. · 2020 · Emerging infectious diseases
60. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19
    Gunawan Widjaja, Abduladheem Turki Jalil, Heshu Sulaiman Rahman, Walid Kamal Abdelbasset, Dmitry Olegovich Bokov, Wanich Suksatan, Mahnaz Ghaebi, Faroogh Marofi, Jamshid Gholizadeh Navashenaq, Farhad Jadidi‐Niaragh et al. · 2021 · Human Immunology
61. COVID-19: progression of disease and intravascular coagulation – present status and future perspectives
    Job Harenberg, Emmanuel J. Favaloro · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
62. Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
    Mar Masiá, Marta Fernández‐González, Sergio Padilla, Piedad Ortega, José Alberto García, Vanesa Agulló, Javier García‐Abellán, Guillermo Telenti, Lucía Guillén, Félix Gutiérrez · 2020 · EBioMedicine
63. Breadth and function of antibody response to acute SARS-CoV-2 infection in humans
    Kuan-Ying A. Huang, T. Tan, Ting-Hua Chen, Chung-Guei Huang, R. Harvey, S. Hussain, Cheng-Pin Chen, Adam C. Harding, J. Gilbert-Jaramillo, Xu Liu et al. · 2021 · PLoS Pathogens
64. Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
    Haya Altawalah · 2021 · Vaccines
65. Will antibody tests for the coronavirus really change everything?
    Mallapaty, Smriti · 2020 · Nature
66. Recurrence or Relapse of COVID ‐19 in Older Patients: A Description of Three Cases
    Ludovic Lafaie, Thomas Célarier, Luc Goethals, Bruno Pozzetto, Sylvain Grange, Étienne Ojardias, Cédric Annweiler, Élisabeth Botelho-Nevers · 2020 · Journal of the American Geriatrics Society
67. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019
    Lee, Jee-Soo, Kim, So Yeon, Kim, Taek Soo, Hong, Ki Ho, Ryoo, Nam-Hee, Lee, Jaehyeon, Park, Jae Hyeon, Cho, Sung Im, Kim, Man Jin, Kim, Young-gon et al. · 2021 · Clinical Infectious Diseases
68. Serological follow-up of SARS-CoV-2 asymptomatic subjects
    Gregorio Paolo Milani, Laura Dioni, Chiara Favero, Laura Cantone, Chiara Macchi, Serena Delbue, Matteo Bonzini, Emanuele Montomoli, Valentina Bollati, Benedetta Albetti et al. · 2020 · Scientific Reports
69. Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study
    Xiaoyong Zhang, Suwen Lu, Hui Li, Yi Wang, Zhen Lu, Zhihong Liu, Qingtao Lai, Yali Ji, Xuan Huang, Yongyin Li et al. · 2020 · Virologica Sinica
70. Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution
    Supriya Ravichandran, Youri Lee, Gabrielle Grubbs, Elizabeth M. Coyle, Laura Klenow, Osamu Akasaka, Michiko Koga, Eisuke Adachi, Makoto Saito, Ichiro Nakachi et al. · 2021 · Science Advances
71. Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
    Jiang, Chuanhao, Wang, Yali, Hu, Min, Wen, Lingjun, Wen, Chuan, Wang, Yang, Zhu, Weihong, Tai, Shi, Jiang, Zhongbiao, Xiao, Kui et al. · 2020 · Clinical & Translational Immunology
72. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study
    Janine Makaronidis, Jessica Mok, Nyaladzi Balogun, Cormac G. Magee, Rumana Omar, Alisia Carnemolla, Rachel Louise Batterham · 2020 · PLoS Medicine
73. Recommendations for Trauma and Emergency General Surgery Practice During COVID-19 Pandemic
    Ali Fuat Kaan Gok · 2020 · Turkish Journal of Trauma and Emergency Surgery
74. Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic
    M. Pulia, T. O'Brien, Peter C. Hou, Andrew Schuman, R. Sambursky · 2020 · Annals medicus
75. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients
    Souheil Zayet, Timothée Klopfenstein, Julien Mercier, N’dri Juliette Kadiane-Oussou, Ludovic Lan Cheong Wah, Pierre-Yves Royer, Lynda Toko, Vincent Gendrin · 2020 · Infection
76. The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers?
    Kevin Lamote, Eline Janssens, Eline Schillebeeckx, Therese Sophie Lapperre, Benedicte Y. De Winter, Jan P. van Meerbeeck · 2020 · Journal of Breath Research
77. Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World
    Robin Augustine, Suvarthi Das, Anwarul Hasan, Abhilash S, Shaheen Abdul Salam, Priya Augustine, Yogesh Bharat Dalvi, Ruby Varghese, Rosita Primavera, Hadi Mohamad Yassine et al. · 2020 · Journal of Clinical Medicine
78. Rapid and Sensitive SERS-Based Lateral Flow Test for SARS-CoV2-Specific IgM/IgG Antibodies
    Supriya Srivastav, Asen Dankov, Mujo Adanalic, Roland Grzeschik, Vi Thuy Tran, Sibylle Pagel‐Wieder, Frank Gessler, Ingo Spreitzer, Tatjana Scholz, Barbara S. Schnierle et al. · 2021 · Analytical Chemistry
79. COVID-19 — Toward a comprehensive understanding of the disease
    Maciej Michał Kowalik, Piotr Trzonkowski, Magdalena Łasińska-Kowara, Andrzej Mital, Tomasz Smiatacz, Milosz Jaroslaw Jaguszewski · 2020 · Cardiology Journal
80. Combination of serological total antibody and RT-PCR test for detection of SARS-COV-2 infections
    Pei Wang · 2020 · Journal of Virological Methods
81. Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients
    Xuefeng Niu, Song Li, Pingchao Li, Wenjing Pan, Qian Wang, Ying Feng, Xiaoneng Mo, Qihong Yan, Xianmiao Ye, Jia Liang Luo et al. · 2020 · Frontiers in Immunology
82. COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern
    Md. Zeyaullah, Abdullah M. AlShahrani, Khursheed Muzammil, Irfan Ahmad, Shane Alam, Wajihul Hasan Khan, Razi Ahmad · 2021 · Frontiers in Genetics
83. Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
    Rami S. Alqassieh, Aiman Suleiman, Sami A. Abu‐Halaweh, Abeer Santarisi, Omar Shatnawi, Lara Shdaifat, Amjed Adnan Tarifi, Mohammad Al‐Tamimi, Abdel-Ellah Al-Shudifat, Heba Alsmadi et al. · 2021 · Vaccines
84. Returning to orthopaedic business as usual after COVID-19: strategies and options
    Francesca de Caro, Thomas Michael Hirschmann, PETER C.M. VERDONK · 2020 · Knee Surgery Sports Traumatology Arthroscopy
85. Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2
    Wei Li, Yingying Su, Shenshen Zhi, Jian Huang, C.-L. Zhuang, Weizhi Bai, Y. Wan, Xiangrui Meng, Litao Zhang, Yibiao Zhou et al. · 2020 · Clinical Microbiology and Infection
86. SARS-CoV-2 serosurvey in health care workers of the Veneto Region
    Mario Plebani, Andrea Padoan, Ugo Fedeli, Elena Schievano, Elena Vecchiato, Giuseppe Lippi, Giuliana Lo Cascio, Stefano Porru, Giorgio Palù · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
87. Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
    Ali Hamady, JinJu Lee, Zuzanna Loboda · 2021 · Infection
88. Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City
    Mayce Mansour, Emily A. Leven, Kimberly Muellers, Kimberly Stone, Damodara Rao Mendu, Ania Wajnberg · 2020 · Journal of General Internal Medicine
89. Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS
    Walter Fierz, Brigitte Walz · 2020 · Frontiers in Immunology
90. Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant
    Petra Mlčochová, Dami A. Collier, Allyson V. Ritchie, Sonny Michael Assennato, Myra D.T. Hosmillo, Neha Goel, Bo Meng, Krishna Chatterjee, Vivien Mendoza, Nigel James Temperton et al. · 2020 · Cell Reports Medicine
91. SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis
    Ada Aita, Daniela Basso, Anna Maria Cattelan, Paola Fioretto, Filippo Navaglia, Francesco Barbaro, Alice Stoppa, Enrico Coccorullo, Assunta Farella, Aurora Socal et al. · 2020 · Clinica Chimica Acta
92. Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative
    Yunying Zhou, Fengyan Pei, Li Wang, 赵怀龙, Huanjie Li, Huanjie Li, Weihua Yang, Qingxi Wang, Qianqian Zhao, Yunshan Wang · 2020 · PLoS ONE
93. Fast Screening and Primary Diagnosis of COVID-19 by ATR FT-IR
    Liyang Zhang, Meng Xiao, Yao Wang, Siqi Peng, Yu Chen, Dong Zhang, Dongheyu Zhang, Yuntao Guo, Xinxin Wang, Haiyun Luo et al. · 2020 · Analytical Chemistry
94. A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
    Allison N. Grossberg, Lilia A. Koza, Aurélie Ledreux, C. Prusmack, H. Krishnamurthy, V. Jayaraman, A. Granholm, D. Linseman · 2021 · Nature Communications
95. Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19
    Whitney E. Harrington, Olesya Trakhimets, Daniela V. Andrade, Nicholas Dambrauskas, Andrew Raappana, Yonghou Jiang, John Houck, William Selman, Ashton Yang, Vladimir I. Vigdorovich et al. · 2021 · Cell Reports Medicine
96. Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients
    Andrew D. Moura, Hernan Hermes Monteiro da Costa, Victor Araujo Correa, Ana K. de S. Lima, José Ângelo Lauletta Lindoso, Elizabeth De Gaspari, Marisa Ailin Hong, Jair Pereira Cunha-Junior, Carlos Roberto Prudêncio · 2021 · Scientific Reports
97. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
    Jun Wu, Boyun Liang, Cunrong Chen, Hua Wang, Yaohui Fang, Shū Shěn, Xiaoli Yang, Baoju Wang, Liangkai Chen, Qi Chen et al. · 2020 · medRxiv
98. Optimization of group size in pool testing strategy for SARS‐CoV‐2: A simple mathematical model
    Diego Aragón‐Caqueo, Javier Fernández‐Salinas, D. Laroze · 2020 · Journal of Medical Virology
99. Perspectives of Immune Therapy in Coronavirus Disease 2019
    Armen Yuri Gasparyan, Durga Prasanna Misra, Marlen Yessirkepov, Olena Zimba · 2020 · Journal of Korean Medical Science
100. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study
     Felipe Pérez‐García, Ramón Pérez‐Tanoira, Juan Romanyk, Teresa Arroyo, Peña Gómez-Herruz, Juan Cuadros‐González · 2020 · Journal of Clinical Virology